PKIDs News

Hand-picked news for the PKIDs community

AMEDEO Hepatitis Articles 05/12/10

with one comment

1. KUNIHOLM MH, Labrique AB, Nelson KE.
Should HIV-infected patients with unexplained chronic liver enzyme
elevations be tested for hepatitis E virus?
Clin Infect Dis. 2010;50:1545-6.
http://amedeo.com/p2.php?id=20433358&s=hep&pm=55fdd48ca73ce1a

2. SCHLAGENHAUF P, Chen LH, Wilson ME, Freedman DO, et al.
Sex and Gender Differences in Travel-Associated Disease.
Clin Infect Dis. 2010.
http://amedeo.com/p2.php?id=20156059&s=hep&pm=55fdd48ca73ce1a
ABSTRACT available

3. MUSALLAM KM, Sharara AI, Inati A, Taher AT, et al.
The role of liver iron in hepatitis C antiviral treatment.
Eur J Gastroenterol Hepatol. 2010;22:769.
http://amedeo.com/p2.php?id=20440118&s=hep&pm=55fdd48ca73ce1a

4. ALONSO RODRIGUEZ L, Barcina Pajares R, Fuentes Vigil J, Gutierrez Gonzalez A, et al.
[Acute toxic hepatitis secondary to a single dose of bupropion.]
Gastroenterol Hepatol. 2010.
http://amedeo.com/p2.php?id=20435378&s=hep&pm=55fdd48ca73ce1a

5. NARVAEZ RODRIGUEZ I, Jimenez Jaen C.
[Hepatitis B virus and celiac disease.]
Gastroenterol Hepatol. 2010.
http://amedeo.com/p2.php?id=20434813&s=hep&pm=55fdd48ca73ce1a

6. AGHEMO A, Colombo M.
Genetic Variation in Interleukin-28B Predicts Hepatitis C Treatment-Induced
Viral Clearance in Genotype 1 Patients: The Dawn of a New Era?
Gastroenterology. 2010.
http://amedeo.com/p2.php?id=20434505&s=hep&pm=55fdd48ca73ce1a

7. HONDA M, Sakai A, Yamashita T, Nakamoto Y, et al.
Hepatic ISG expression is associated with genetic variation in IL28B and the
outcome of IFN therapy for chronic hepatitis C.
Gastroenterology. 2010.
http://amedeo.com/p2.php?id=20434452&s=hep&pm=55fdd48ca73ce1a
ABSTRACT available

8. LIU J, Yang HI, Lee MH, Lu SN, et al.
Incidence and Determinants of Spontaneous Hepatitis B Surface Antigen
Seroclearance: A Community-based Follow-up Study.
Gastroenterology. 2010.
http://amedeo.com/p2.php?id=20434450&s=hep&pm=55fdd48ca73ce1a
ABSTRACT available

9. DAI CY, Huang CF, Huang JF, Chuang WL, et al.
Hepatitis C virus genotype 2/3 patients who can receive an abbreviated
course of peginterferon/ribavirin: the important role of initial ribavirin doses.
Hepatology. 2010;51:1861-2.
http://amedeo.com/p2.php?id=20432270&s=hep&pm=55fdd48ca73ce1a

10. ALTINBAS A, Coban S, Yuksel O.
Fibrosis in liver as a predictive marker for hepatitis C virus therapy.
Hepatology. 2010;51:1858.
http://amedeo.com/p2.php?id=20432265&s=hep&pm=55fdd48ca73ce1a

11. EYRE NS, Beard MR.
Hepatitis C virus infection in living color.
Hepatology. 2010;51:1852-5.
http://amedeo.com/p2.php?id=20432262&s=hep&pm=55fdd48ca73ce1a

12. HALL AJ.
Boosters for hepatitis B vaccination? Need for an evidence-based policy.
Hepatology. 2010;51:1485-6.
http://amedeo.com/p2.php?id=20432250&s=hep&pm=55fdd48ca73ce1a

13. EFE C, Purnak T, Ozaslan E.
Concurrent Autoimmune Thyroid Diseases in Patients With Autoimmune Hepatitis.
J Clin Gastroenterol. 2010.
http://amedeo.com/p2.php?id=20431396&s=hep&pm=55fdd48ca73ce1a

14. CIESEK S, Friesland M, Steinmann J, Becker B, et al.
How Stable Is the Hepatitis C Virus (HCV)? Environmental Stability of HCV
and Its Susceptibility to Chemical Biocides.
J Infect Dis. 2010.
http://amedeo.com/p2.php?id=20441517&s=hep&pm=55fdd48ca73ce1a
ABSTRACT available

15. CHAPMAN MH, Kajihara M, Borges G, O’Beirne J, et al.
Severe, acute liver injury and khat leaves.
N Engl J Med. 2010;362:1642-4.
http://amedeo.com/p2.php?id=20427816&s=hep&pm=55fdd48ca73ce1a

16. MURRAY CL, Rice CM.
Hepatitis C: An unsuspected drug target.
Nature. 2010;465:42-4.
http://amedeo.com/p2.php?id=20445618&s=hep&pm=55fdd48ca73ce1a

17. SOKUCU S, Gokce S, Gulluoglu M, Aydogan A, et al.
The role of the non-invasive serum marker FibroTest-ActiTest in the prediction
of histological stage of fibrosis and activity in children with naive chronic hepatitis B infection.
Scand J Infect Dis. 2010.
http://amedeo.com/p2.php?id=20429710&s=hep&pm=55fdd48ca73ce1a
ABSTRACT available

18. MARSHALL H, Nolan T, Diez Domingo J, Rombo L, et al.
Long-term (5-year) antibody persistence following two- and three-dose
regimens of a combined hepatitis A and B vaccine in children aged 1-11 years.
Vaccine. 2010.
http://amedeo.com/p2.php?id=20434544&s=hep&pm=55fdd48ca73ce1a
ABSTRACT available

19. ROUKENS AH, Vossen AC, Boland GJ, Verduyn W, et al.
Intradermal hepatitis B vaccination in non-responders after topical
application of imiquimod (Aldara((R))).
Vaccine. 2010.
http://amedeo.com/p2.php?id=20433806&s=hep&pm=55fdd48ca73ce1a
ABSTRACT available

20. DUAN H, Struble E, Zhong L, Mihalik K, et al.
Hepatitis C virus with a naturally occurring single amino-acid substitution
in the E2 envelope protein escapes neutralization by naturally-induced and
vaccine-induced antibodies.
Vaccine. 2010.
http://amedeo.com/p2.php?id=20433800&s=hep&pm=55fdd48ca73ce1a
ABSTRACT available

Advertisements

Written by pkids

May 10, 2010 at 3:55 pm

Posted in Hepatitis

One Response

Subscribe to comments with RSS.

  1. very informative—thanks =0)

    Mom

    January 5, 2011 at 3:45 pm


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: